Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year
Stratipath has been recognized as one of the Gold Companies on NyTeknik – First with news about technology and IT. and AffĂ€rsvĂ€rldenâs prestigious 33-list â for the maximum three consecutive years!
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göranâs Hospital
Capio St Göranâs Hospital is one of the largest breast cancer clinics in Sweden treating more than 600 breast cancer patients annually. With this new collaboration, Unilabs will use Stratipath Breast on a selected group of these patients.
Article in âOncology in Swedenâ on the continuation of SwAIPP (Sweden AI Precision Pathology)
SwAIPP 2, the continuation of the SwAIPP project, has been funded by Swedenâs innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry.
Podcast: âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â
Johan Hartman is a guest at the Johnson & Johnson podcast âVi forskar för livetâ (âResearch for Lifeâ). The episode, titled âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â
Article at Genomeweb: âStratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Testâ
Johan Hartman is a guest at the Johnson & Johnson podcast âVi forskar för livetâ (âResearch for Lifeâ). The episode, titled âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â
TV4 morning show: Report: New Drugs Are Not Reaching All Breast Cancer Patients
Advances in breast cancer research are providing entirely new opportunities to diagnose and treat the most common cancer among women. Today, the Breast Cancer Association is releasing a report on access to the advanced diagnostic methods needed to determine whether a patient will benefit from specific medications, known as precision diagnostics. Susanne Dieroff Hay, Chair of the Breast Cancer Association, and Johan Hartman, tumor pathologist at Karolinska University Hospital, share their insights.
Unilabs Sverige and St. Göranâs Hospital are soon adopting Stratipath Breast for breast cancer risk profiling.
Johan Hartman is a guest at the Johnson & Johnson podcast âVi forskar för livetâ (âResearch for Lifeâ). The episode, titled âPrecision Medicine is the Future of Healthcare â But Do We Have the Skills Needed?â
Article in Impact loop.
âWe have the first product in this field approved for hospital use. But AI is advancing rapidly, so there will be competition, which is great. The market is large, so thereâs room for more players.â
Stratipath and Roche Join Forces to Help Expand Access to AI-Powered Precision Diagnostics
Stratipath is thrilled to announce a collaboration with Roche, the worldâs largest biotechnology company and the global leader in in-vitro diagnostics.
Webinar: Prognostic Tools in Breast Cancer Care
In collaboration with iBreastBook, Johan Hartman, co-founder of Stratipath, participated in a webinar focused on predictive and prognostic tools in breast cancer care. Johan delivered an insightful lecture on: âAI-Based Image Analysis: A Cost-Effective Alternative to Genomic Profilingâ. We were honored to have an excellent lineup of speakers and panelists who shared their expertise:– Abeer […]
